Affiliation:
1. From the Institut für Pharmakologie und Toxikologie (F.B.), Karl-Franzens-Universität Graz, A-8010 Graz, Austria, and University of Cape Town Medical School (L.H.O.), Ischaemic Heart Disease Research Unit, Cape Town, South Africa.
Abstract
Background
—Circulating endothelin (ET)-1 is elevated in ischemia/reperfusion and may exert proischemic effects. The aim of the present study was to characterize the effects of ET-1 in rat isolated hearts using subtype-selective ET receptor antagonists, agents modulating the cytosolic Ca
2+
concentration, or the activity of cGMP-dependent protein kinase.
Methods and Results
—Rat hearts perfused at constant pressure were made ischemic by reducing flow to 0.2 mL · min
-1
· g
−1
, followed by reperfusion at normal pressure (each phase, 25 minutes). Drugs were infused during the ischemic phase only. Parameters monitored were extent and time-to-onset of contracture in ischemia, left ventricular developed pressure (LVDevP), coronary flow (CF), and diastolic relaxation during reperfusion. The ET
A
receptor-selective antagonist PD 155080 (50 nmol/L) reduced peak ischemic contracture (−49%) and delayed its time to onset (+56%) and improved recovery of reperfusion LVDevP (+12%), CF (+16%), and diastolic relaxation (+50%). Infusion of an ET
A
/ET
B
-nonselective antagonist, PD 142893 (200 nmol/L), had similar effects on all parameters, whereas infusion of BQ-788 (20 nmol/L), an ET
B
receptor-selective antagonist, was without effect. Exogenous ET-1 (100 pmol/L) hastened contracture and increased its extent (+23%) and reduced recovery of both LVDevP (−31%) and CF (−18%), effects that were counteracted by HOE 642 (10 μmol/L), a Na
+
/H
+
exchange inhibitor, but not by nicardipine (30 μmol/L), a Ca
2+
entry blocker; activation of cGMP-dependent protein kinase by the cell-permeable cGMP analog Sp-8-p-chlorophenylthioguanosine-3’,5’-cyclic monophosphorothioate (10 μmol/L) improved function without preventing the effects of ET-1.
Conclusions
—The data indicate that ET-1 exacerbates ischemic contracture and worsens ventricular and coronary reperfusion dysfunction by activating ET
A
receptors via a mechanism likely involving activation of Na
+
/H
+
exchange in this model.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献